Back to ONC

BeOne Medicines Ltd. Depreciation & Amortization 2014-2026 | ONC

Beta

What is depreciation & amortization?

Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.

What is BeOne Medicines Ltd.'s current depreciation & amortization?

BeOne Medicines Ltd. (ONC) annual depreciation & amortization for 2025 was $141.7M, a 17.51% decline from 2024. BeOne Medicines Ltd. depreciation & amortization for the quarter ending March 31, 2026 was $41.1M.

What was BeOne Medicines Ltd.'s depreciation & amortization in 2024?

BeOne Medicines Ltd. annual depreciation & amortization for 2024 was $171.8M, a 95.91% increase from 2023.

What was BeOne Medicines Ltd.'s depreciation & amortization in 2023?

BeOne Medicines Ltd. annual depreciation & amortization for 2023 was $87.7M, a 32.28% increase from 2022.

What is BeOne Medicines Ltd.'s 5-year depreciation & amortization CAGR?

BeOne Medicines Ltd. depreciation & amortization grew at a compound annual growth rate (CAGR) of 34.84% from FY2020 to FY2025, going from $31.8M to $141.7M over 5 years.

Depreciation & Amortization History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+34.8%
FY2020
$31.8M
→
FY2025
$141.7M
141516171819202122232425
5 years selected
Depreciation & Amortization History
PeriodValueChangeSource
FY2025$141.7M-17.5%10-K
FY2024$171.8M+95.9%10-K
FY2023$87.7M+32.3%10-K
FY2022$66.3M+42.7%10-K
FY2021$46.5M+46.1%10-K
FY2020$31.8M+70.8%10-K
FY2019$18.6M+79.2%10-K
FY2018$10.4M+118.3%10-K
FY2017$4.8M+149.2%10-K
FY2016$1.9M+23.6%10-K
FY2015$1.5M-0.8%10-K
FY2014$1.6M-10-K
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →